Colby Tubbs, Mary Lauren Benton, Evonne McArthur, John A Capra, Douglas M Ruderfer
{"title":"Identifying deleterious noncoding variation through gain and loss of CTCF binding activity.","authors":"Colby Tubbs, Mary Lauren Benton, Evonne McArthur, John A Capra, Douglas M Ruderfer","doi":"10.1016/j.ajhg.2025.02.009","DOIUrl":null,"url":null,"abstract":"<p><p>CCCTC binding factor (CTCF) regulates gene expression through DNA binding at thousands of genomic loci. Genetic variation in these CTCF binding sites (CBSs) is an important driver of phenotypic variation, yet extracting those that are likely to have functional consequences in whole-genome sequencing remains challenging. To address this, we develop a hypothesis-driven framework to identify and prioritize CBS variants in gnomAD. We synthesize CTCF's binding patterns at 1,063,878 genomic loci across 214 biological contexts into a summary of binding activity. We find that high binding activity significantly correlates with both conserved nucleotides (Pearson R = 0.35, p < 2.2 × 10<sup>-16</sup>) and sequences that contain high-quality CTCF binding motifs (Pearson R = 0.63, p = 2.9 × 10<sup>-12</sup>). We then use binding activity to evaluate high-confidence allelic binding predictions for 1,253,329 single-nucleotide variations (SNVs) in gnomAD that disrupt a CBS. We find a strong, positive relationship between the mutability-adjusted proportion of singletons (MAPS) metric and the loss of CTCF binding at loci with high in vitro activity (Pearson R = 0.74, p < 2.2 × 10<sup>-16</sup>). To contextualize these findings, we apply MAPS to other functional classes of variation and find that a subset of 339,380 loss of CTCF binding variants is observed as infrequently as missense variants are. This work nominates these thousands of rare, noncoding variants that disrupt CTCF binding for further functional studies while providing a blueprint for prioritizing variation in other transcription factor binding sequences.</p>","PeriodicalId":7659,"journal":{"name":"American journal of human genetics","volume":" ","pages":"892-902"},"PeriodicalIF":8.1000,"publicationDate":"2025-04-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12081274/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"American journal of human genetics","FirstCategoryId":"99","ListUrlMain":"https://doi.org/10.1016/j.ajhg.2025.02.009","RegionNum":1,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/3/5 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"GENETICS & HEREDITY","Score":null,"Total":0}
引用次数: 0
Abstract
CCCTC binding factor (CTCF) regulates gene expression through DNA binding at thousands of genomic loci. Genetic variation in these CTCF binding sites (CBSs) is an important driver of phenotypic variation, yet extracting those that are likely to have functional consequences in whole-genome sequencing remains challenging. To address this, we develop a hypothesis-driven framework to identify and prioritize CBS variants in gnomAD. We synthesize CTCF's binding patterns at 1,063,878 genomic loci across 214 biological contexts into a summary of binding activity. We find that high binding activity significantly correlates with both conserved nucleotides (Pearson R = 0.35, p < 2.2 × 10-16) and sequences that contain high-quality CTCF binding motifs (Pearson R = 0.63, p = 2.9 × 10-12). We then use binding activity to evaluate high-confidence allelic binding predictions for 1,253,329 single-nucleotide variations (SNVs) in gnomAD that disrupt a CBS. We find a strong, positive relationship between the mutability-adjusted proportion of singletons (MAPS) metric and the loss of CTCF binding at loci with high in vitro activity (Pearson R = 0.74, p < 2.2 × 10-16). To contextualize these findings, we apply MAPS to other functional classes of variation and find that a subset of 339,380 loss of CTCF binding variants is observed as infrequently as missense variants are. This work nominates these thousands of rare, noncoding variants that disrupt CTCF binding for further functional studies while providing a blueprint for prioritizing variation in other transcription factor binding sequences.
CCCTC结合因子(CTCF)通过数千个基因组位点的DNA结合调控基因表达。这些CTCF结合位点(CBSs)的遗传变异是表型变异的重要驱动因素,然而在全基因组测序中提取那些可能具有功能影响的基因仍然具有挑战性。为了解决这个问题,我们开发了一个假设驱动的框架来识别gnomAD中的CBS变体并确定其优先级。我们将CTCF在214个生物学背景下的1,063,878个基因组位点的结合模式合成为结合活性摘要。我们发现高结合活性与保守核苷酸(Pearson R = 0.35, p -16)和含有高质量CTCF结合基序的序列(Pearson R = 0.63, p = 2.9 × 10-12)显著相关。然后,我们使用结合活性来评估gnomAD中破坏CBS的1,253,329个单核苷酸变异(snv)的高置信度等位基因结合预测。我们发现,突变调整后的单子比例(MAPS)指标与体外高活性位点上CTCF结合的丧失之间存在强烈的正相关(Pearson R = 0.74, p -16)。为了将这些发现联系起来,我们将MAPS应用于变异的其他功能类别,发现339,380个CTCF结合变异的缺失子集与错义变异一样罕见。这项工作为进一步的功能研究提供了数千种罕见的、破坏CTCF结合的非编码变异,同时为其他转录因子结合序列的变异优先排序提供了蓝图。
期刊介绍:
The American Journal of Human Genetics (AJHG) is a monthly journal published by Cell Press, chosen by The American Society of Human Genetics (ASHG) as its premier publication starting from January 2008. AJHG represents Cell Press's first society-owned journal, and both ASHG and Cell Press anticipate significant synergies between AJHG content and that of other Cell Press titles.